03 — Apoptosis: Intrinsic and Extrinsic Pathways

Core Explanation

Programmed cell death is an essential process in multicellular organisms. It eliminates damaged, infected, or superfluous cells without triggering inflammation, sculpts tissues during development, and maintains homeostasis in proliferative tissues. Apoptosis is the best-understood form of programmed cell death — a tightly regulated, energy-dependent, caspase-mediated process.

Apoptosis vs. Necrosis

The important modern update is that necrosis is not always accidental. Regulated necrosis pathways, most notably necroptosis, are now recognized as genetically encoded cell-death programs. Necroptosis is executed by the RIPK1–RIPK3–MLKL axis and can serve as a fail-safe when apoptosis is blocked (e.g., by caspase inhibitors expressed by certain viruses).

The Intrinsic (Mitochondrial) Pathway

The intrinsic pathway is activated by intracellular stress: DNA damage, oncogene activation, growth factor withdrawal, endoplasmic reticulum stress, or cytotoxic drugs. Its central regulatory hub is the Bcl-2 protein family and its point of no return is mitochondrial outer membrane permeabilization (MOMP).

Bcl-2 Family Architecture

The Bcl-2 family is divided into three functional groups, all sharing one or more Bcl-2 homology (BH) domains:

The MOMP Decision

In healthy cells, anti-apoptotic Bcl-2 family members bind and neutralize both the BH3-only sensors and any stray Bax/Bak molecules. When a death stimulus arrives:

1. Specific BH3-only proteins are transcriptionally induced or post-translationally activated. For example, p53 directly transcribes PUMA and NOXA in response to irreparable DNA damage; growth factor withdrawal dephosphorylates and activates Bim.
2. "Sensitizer" BH3-only proteins (Bad, Noxa) bind and neutralize anti-apoptotic Bcl-2 proteins, freeing any already-activated Bax/Bak.
3. "Activator" BH3-only proteins (Bid after cleavage by caspase-8, Bim, Puma) directly bind Bax/Bak, inducing their conformational change, mitochondrial translocation, and oligomerization.
4. Bax/Bak oligomers form pores in the outer mitochondrial membrane → MOMP.

Downstream of MOMP

Once MOMP occurs, the intermembrane-space proteins are released into the cytosol:

1. Cytochrome c binds Apaf-1 (apoptotic protease-activating factor 1). In the presence of dATP/ATP, Apaf-1 oligomerizes into a heptameric wheel-like structure called the apoptosome.
2. The apoptosome recruits and activates caspase-9 (the initiator caspase of the intrinsic pathway) through induced-proximity dimerization.
3. Active caspase-9 cleaves and activates the executioner caspases — caspase-3 and caspase-7.
4. Executioner caspases cleave ~600–1,000 cellular substrates, producing the apoptotic phenotype: ICAD cleavage frees CAD for DNA fragmentation, PARP cleavage disables DNA repair, lamin cleavage dismantles the nuclear lamina, ROCK1 cleavage drives membrane blebbing, and the phospholipid scramblase Xkr8 is activated to expose phosphatidylserine on the outer leaflet.

MOMP also releases Smac/DIABLO and Omi/HtrA2, which neutralize IAPs (Inhibitor of Apoptosis Proteins). IAPs (XIAP, cIAP1, cIAP2) bind and inhibit caspases; Smac/DIABLO displaces them by binding IAP BIR domains through its N-terminal AVPI motif, analogous to how caspases bind IAPs.

The Extrinsic (Death Receptor) Pathway

The extrinsic pathway is triggered by extracellular ligands binding to cell-surface death receptors of the TNF receptor superfamily.

The Fas/CD95 Pathway (Prototype)

1. Fas ligand (FasL), a trimeric transmembrane protein on cytotoxic T lymphocytes or NK cells, binds trimeric Fas (CD95/APO-1) receptors on the target cell.
2. Receptor clustering recruits the adaptor protein FADD (Fas-associated death domain) via homotypic death-domain (DD) interactions.
3. FADD contains a death effector domain (DED) that recruits procaspase-8 (and procaspase-10 in humans) through DED–DED interactions.
4. The assembled multiprotein complex is called the DISC (Death-Inducing Signaling Complex). At the DISC, procaspase-8 monomers are brought into close proximity, leading to dimerization and autocatalytic cleavage into active caspase-8.

Two Cell-Type-Dependent Outcomes (Type I vs. Type II Cells)

• Type I cells (e.g., thymocytes): The DISC generates sufficient active caspase-8 to directly cleave and activate executioner caspases (caspase-3/7). Apoptosis proceeds without mitochondrial involvement.
• Type II cells (e.g., hepatocytes): The DISC produces low amounts of active caspase-8, insufficient to directly activate executioner caspases. Instead, caspase-8 cleaves the BH3-only protein Bid to generate tBid (truncated Bid). tBid translocates to mitochondria, activates Bax/Bak, triggers MOMP, and amplifies the death signal through the intrinsic pathway. The two pathways thus converge at the level of mitochondrial permeabilization.

Other Death Receptors

Crosstalk Between Pathways

The critical crosstalk node is Bid → tBid (caspase-8 cleavage of Bid). This creates a direct connection from the extrinsic pathway to the mitochondrial amplification loop. In Type II cells, this crosstalk is essential — extrinsic signals cannot kill the cell without engaging the intrinsic pathway. Other crosstalk includes:

• XIAP inhibition by Smac/DIABLO: Even in extrinsic-pathway-dominant cells, mitochondrial release of Smac/DIABLO can relieve XIAP-mediated caspase inhibition, synergistically enhancing death.
• Bcl-2 overexpression: Blocks intrinsic-pathway death and, in Type II cells, blocks extrinsic-pathway death by preventing MOMP downstream of tBid. In Type I cells, Bcl-2 overexpression provides little protection because caspase-8 directly activates executioner caspases without mitochondrial amplification.

Questions

Q1: How can a cancer cell overexpressing Bcl-2 evade apoptosis induced by chemotherapy, and why does this resistance mechanism not apply equally to all death stimuli?

A1: Bcl-2 overexpression prevents MOMP by binding and neutralizing BH3-only proteins and Bax/Bak. Most chemotherapeutic agents ultimately kill via the intrinsic pathway (DNA damage → p53 → Puma/Noxa → Bax/Bak → MOMP), so Bcl-2 overexpression directly blocks their lethal signal. However, in Type I cells stimulated through the extrinsic pathway (e.g., by cytotoxic T cells delivering FasL), active caspase-8 directly cleaves executioner caspases without needing mitochondrial amplification, so Bcl-2 provides no protection. This distinction has clinical relevance — immune-mediated tumor clearance can sometimes succeed against tumors that are chemoresistant due to Bcl-2 upregulation.

Q2: Explain why MOMP is considered the "point of no return" in apoptosis, even though caspase activation occurs downstream of MOMP.

A2: MOMP is irreversible for several reasons: (1) The mitochondrial outer membrane cannot be re-sealed once Bax/Bak pores form — the damage is structural. (2) Cytochrome c release not only activates caspases via the apoptosome but also disrupts the electron transport chain, collapsing the mitochondrial membrane potential (ΔΨm), halting ATP production, and generating reactive oxygen species. Even if caspases are pharmacologically inhibited, the cell after MOMP has lost its bioenergetic capacity and will die by a slower, caspase-independent necrosis-like process. Caspase inhibitors can prevent the morphological features of apoptosis but cannot rescue a cell past MOMP. This is why the Bcl-2 family, which controls MOMP, is the critical decision-making node.

Q3: Contrast the signaling logic of the DISC (extrinsic) and the apoptosome (intrinsic). Why are two different initiator caspase activation platforms needed?

A3: Both are induced-proximity activation platforms, but they solve different problems. The DISC is a membrane-proximal complex assembled rapidly (minutes) at the plasma membrane in response to an extracellular signal; it uses DED–DED interactions (FADD to caspase-8) and is designed for speed and signal amplification from low-abundance ligand. The apoptosome is a cytosolic, cytochrome c-triggered platform assembled around Apaf-1's nucleotide-binding domain; it uses CARD–CARD interactions (Apaf-1 to caspase-9) and is designed to integrate diverse intracellular stress signals into a single, all-or-nothing decision. The two platforms exist because the cell needs both external policing (immune surveillance, eliminating infected cells) and internal quality control (eliminating damaged or aneuploid cells). The Bid/tBid crosstalk ensures these two surveillance systems communicate.